Protagenic Therapeutics, Inc. (PTIX)
$0.77+1.32%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1M
- Beta
- 1.07
- P/E (TTM)
- 0.26
- Short % float
- 0.75%
- Days to cover
- 1.2
- SI change
- +0.4%
- 1W
- +0.00%
- 1M
- -11.49%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- -14.49%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PTIX?
- LOPJLB’s latest quantitative signal on Protagenic Therapeutics, Inc. (PTIX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PTIX in?
- Protagenic Therapeutics, Inc. (PTIX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Protagenic Therapeutics, Inc. (PTIX) do?
- Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.